Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 6/20 | 0.76 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 5/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.34 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29787265 | 1.00 | ADRA2C (0.76) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL24183576 | 0.98 | ADRA2C (0.79) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL30379087 | 0.92 | ADRA2C (0.70) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL24183684 | 0.92 | ADRA2C (0.70) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL24183657 | 0.91 | ADRA2C (0.68) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL29787271 | 0.91 | ADRA2C (0.68) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL25124336 | 0.91 | ADRA2C (0.66) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL29787279 | 0.89 | ADRA2C (0.65) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL24183492 | 0.89 | ADRA2C (0.65) | ADRA2CITGB3ITGA2BMAPK8HRH3 | |
| SCHEMBL30359072 | 0.89 | ADRA2C (0.65) | ADRA2CITGB3ITGA2BMAPK8HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230115270-A1 | INHIBITORS OF ADRENORECEPTOR ADRAC2 | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115270-A1 | INHIBITORS OF ADRENORECEPTOR ADRAC2 | ADRA2C, ADRB2, ADRB3 | ADRA2C 1/4885ITGB3 599/4885ITGA2B 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.